Conclusions: Facilitation using ROTA improves peri-procedural success without increasing complications for severely calcified ULM stenosis. Especially in no HD patients, excellent results were obtained at 1-year. However, the development of TLR-MB had still occurred in 38% of the HD patients despite optimal stent expansion.
TCT-411 DES with bioresorbable polymer in the treatment of true bifurcation lesionsresults of a large registry Antonio Serra 1 , Bernard Chevalier 2 , Thomas Hovasse 2 , Andres Iñiguez 3 , Marie-Claude Morice 4 , Alexander G. Osiev 5 , Jawed Polad 6 Background: Clinical outcomes after treatment of true bifurcation lesions (Medina classification: 1.1.1, 1.0.1 and 0.1.1) are in general inferior when compared to non-true bifurcation lesions (1.1.0, 0.0.1, 0.1.0). Therefore, our aim was to compare clinical outcomes of the patients with true and non-true bifurcation lesions treated with Nobori DES. This stent with open cell design and bioresorbable polymer is expected to perform well in lesions involving bifurcation. Methods: Within the large, prospective, single-arm, multi-centre, eNOBORI registry, 898 patients (1541 lesions) had at least one bifurcation treated. Bifurcation lesions (BL) were divided into true (TBL, 512 patients; 927 lesions) and non-true bifurcation lesions (NTBL, 386 patients; 614 lesions). All adverse events are adjudicated by an independent clinical event committee. Primary endpoint of the study is target lesion failure (TLF) at 1 year. Results: Patients in both groups had similar baseline characteristics, except that patients with TBL were less often male (74.8% vs 81.6%) and presented more often with renal failure (8.1% vs 4.7%). Average number of lesions treated per patient and stents implanted per lesion was higher in TBL than in NTBL (2.46AE1.50 vs 2.15AE1.50; p < 0.01 and 1.28AE0.55 vs. 1.16AE0.43; p < 0.01, respectively). According to the Medina classification, the most frequent lesion type in TBL was [1.1.1] (66.2%), whereas in NTBL, [1.1.0] type was most abundant (42.9%). Direct stenting was more frequent in NTBL (35.9% vs. 22.6%; p<0.01) and procedural success was similar in TBL and NTBL groups (98.2% vs 99.2%). In the TBL group, 3 patients died (1.0%; cardiac), 5 patients had TV-MI (1.7%) and 9 patients a TLR (3.0%) at 12 months, resulting int TLF of 6.0%. In the NTBL group, 1 patient died (0.5%; cardiac), 2 patients had TV-MI (0.9%) and 4 patients a TLR (1.9%), resulting in a TLF of 3.2%. No stent thrombosis were observed in the NTBL whereas 2 definite, subacute ST (0.48%) occurred in TBL patients (p ¼ NS). Conclusions: As expected, clinical outcomes after treatment of true bifurcation lesions were less favorable compared to the non-true bifurcation lesions however, the results of both cohorts are very good up to one year.
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